Justin Letendre

Justin Letendre

Company: Strand Therapeutics Inc.

Job title: Scientist, Synthetic Biology

Seminars:

STX-003: mRNA-based Cancer Therapy for Tumor-Specific Expression of IL-12 via Programmable Genetic Circuits 4:00 pm

• STX-003 is a systemically delivered immune oncology drug targeting solid tumors and metastatic disease • Programmable sensors embedded in STX-003 allow for cell-selective expression • Engineered control using these sensors improves STX-003 tolerability without compromising efficacy in pre-clinical animal modelsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.